Patient Testimonial for IV Immunoglobulin Therapy

Guillain-Barré Syndrome (GBS) is a rare neurological disorder in which the body’s immune system mistakenly attacks the peripheral nerves, leading to muscle weakness and paralysis. The exact cause of GBS is not known, but it is believed to be triggered by an immune response to an infection.

Treatment focuses on managing symptoms and providing supportive care to help promote recovery. Intravenous immunoglobulin (IVIg) treatment is a widely used therapy for GBS. It works by neutralizing harmful antibodies and regulating the immune system, leading to a decrease in the attack on the peripheral nerves. This can help slow down the progression of muscle weakness and improve recovery.

IVIg treatment for GBS is usually well-tolerated, but potential side effects may include headache, fever, and allergic reactions. Close monitoring by healthcare professionals is essential during the administration of IVIg to ensure its safety and efficacy.

Mr. A. Krishnaiah from Nalgonda successfully received IV Immunoglobulin Treatment for Guillain-Barre Syndrome (GBS) at Yashoda Hospitals, Hyderabad, under the supervision of Dr. Bharath Kumar Surisetti, Consultant Neuro Physician.